摘要
本研究构建了编码ILTV主要抗原gB基因的重组DNA疫苗pcDNA-gB,质粒转染293-T细胞的间接免疫表明其表达的蛋白具有免疫反应性。为测定该DNA疫苗的免疫效果,将其与本室保存的重组鸡痘病毒rFPV-gB-gD-IgY分别以单独和混合的方式给4周龄非免疫鸡进行免疫,然后测定ILTV特异性抗体和T淋巴细胞增殖反应。结果表明这2种基因工程疫苗均能诱导鸡产生特异性的体液免疫及细胞免疫应答。其中以pcDNA-gB/rFPV-gB-gD-IgY联合免疫组的效果最好,其诱导的抗体水平已接近于常规弱毒疫苗,而细胞免疫水平则比后者高得多。上述研究结果为ILTV新型疫苗的研究奠定了基础。
A Plasmid DNA vaccine pcDNA-gB expressing gB protein of infectious laryngotracheitis virus（ILTV） Yantai strain was constructed. The expression of viral protein from constructed DNA vaccine was confirmed by an in vitro transcription/translation system and transtection in 293-T cells. To evaluate the prophylactic efficacy of the DNA vaccine, 4-week-old chickens were inoculated with pcDNA-gB plasmid and rFPV- gB-gD-IgY, respectively followed by a booster of rFPV-gB-gD-IgY and pcDNA-gB. Anti-ILTV antibodies and T cell proliferation were detected. The results indicated that both vaccines could elicit specific humeral immune and cellular immune responses. Compared with attenuated vaccines, rFPV-gB-gD-IgY/pcDNA-gB elicited not only similar antibody level of ILTV but stronger T cell proliferation. The study lays foundation on further investigation for the new type of vaccines against ILTV.
出处
《中国病毒学》
CSCD
2006年第5期481-484,共4页
Virologica Sinica
